BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34598830)

  • 1. Parity, menopausal hormone therapy, and risk of ovarian granulosa cell tumor - A population-based case-control study.
    Bryk S; Katuwal S; Haltia UM; Tapper J; Tapanainen JS; Pukkala E
    Gynecol Oncol; 2021 Dec; 163(3):593-597. PubMed ID: 34598830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of various forms of postmenopausal hormone therapy on the risk of ovarian cancer--a population-based case control study from Finland.
    Koskela-Niska V; Pukkala E; Lyytinen H; Ylikorkala O; Dyba T
    Int J Cancer; 2013 Oct; 133(7):1680-8. PubMed ID: 23526244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal hormone therapy-also use of estradiol plus levonorgestrel-intrauterine system is associated with an increased risk of primary fallopian tube carcinoma.
    Koskela-Niska V; Pukkala E; Lyytinen H; Ylikorkala O; Dyba T
    Int J Cancer; 2015 Oct; 137(8):1947-52. PubMed ID: 25846583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Other Primary Malignancies Among Women With Adult-Type Ovarian Granulosa Cell Tumors.
    Bryk S; Pukkala E; Färkkilä A; Heikinheimo M; Unkila-Kallio L; Riska A
    Int J Gynecol Cancer; 2018 Oct; 28(8):1529-1534. PubMed ID: 30036228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well.
    Lyytinen HK; Dyba T; Ylikorkala O; Pukkala EI
    Int J Cancer; 2010 Jan; 126(2):483-9. PubMed ID: 19588504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial cancer associated with various forms of postmenopausal hormone therapy: a case control study.
    Jaakkola S; Lyytinen HK; Dyba T; Ylikorkala O; Pukkala E
    Int J Cancer; 2011 Apr; 128(7):1644-51. PubMed ID: 21280035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control study.
    Savolainen-Peltonen H; Rahkola-Soisalo P; Hoti F; Vattulainen P; Gissler M; Ylikorkala O; Mikkola TS
    BMJ; 2019 Mar; 364():l665. PubMed ID: 30842086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Müllerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors.
    Haltia UM; Hallamaa M; Tapper J; Hynninen J; Alfthan H; Kalra B; Ritvos O; Heikinheimo M; Unkila-Kallio L; Perheentupa A; Färkkilä A
    Gynecol Oncol; 2017 Jan; 144(1):83-89. PubMed ID: 27871721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer risk in postmenopausal women using estradiol-progestin therapy - a nationwide study.
    Koskela-Niska V; Lyytinen H; Riska A; Pukkala E; Ylikorkala O
    Climacteric; 2013 Feb; 16(1):48-53. PubMed ID: 22640598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of TNF-related apoptosis inducing-ligand are decreased in patients with large adult-type granulosa cell tumors-implications for therapeutic potential.
    Färkkilä A; Zauli G; Haltia UM; Pihlajoki M; Unkila-Kallio L; Secchiero P; Heikinheimo M
    Tumour Biol; 2016 Sep; 37(9):11909-11916. PubMed ID: 27067438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland.
    Korhonen K; Auvinen A; Lyytinen H; Ylikorkala O; Pukkala E
    Am J Epidemiol; 2012 Feb; 175(4):309-14. PubMed ID: 22287638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal estrogen therapy and risk of gallstone disease: a population-based case-control study.
    Simonsen MH; Erichsen R; Frøslev T; Rungby J; Sørensen HT
    Drug Saf; 2013 Dec; 36(12):1189-97. PubMed ID: 24174288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of parity on the incidence of ovarian cancer subtypes: a population-based case-control study.
    Toufakis V; Katuwal S; Pukkala E; Tapanainen JS
    Acta Oncol; 2021 Jul; 60(7):850-855. PubMed ID: 33999765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.
    Da Cruz Paula A; da Silva EM; Segura SE; Pareja F; Bi R; Selenica P; Kim SH; Ferrando L; Vahdatinia M; Soslow RA; Vidal A; Gatius S; Przybycin CG; Abu-Rustum NR; Matias-Guiu X; Rubin BP; Reis-Filho JS; DeLair DF; Weigelt B
    Mod Pathol; 2020 Aug; 33(8):1606-1617. PubMed ID: 32203090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary fallopian tube carcinoma risk in users of postmenopausal hormone therapy in Finland.
    Koskela-Niska V; Riska A; Lyytinen H; Pukkala E; Ylikorkala O
    Gynecol Oncol; 2012 Aug; 126(2):241-4. PubMed ID: 22561401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and outcome of recurrence in molecularly defined adult-type ovarian granulosa cell tumors.
    Bryk S; Färkkilä A; Bützow R; Leminen A; Tapper J; Heikinheimo M; Unkila-Kallio L; Riska A
    Gynecol Oncol; 2016 Dec; 143(3):571-577. PubMed ID: 27729108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms underlying social inequality in post-menopausal breast cancer.
    Hvidtfeldt UA
    Dan Med J; 2014 Oct; 61(10):B4922. PubMed ID: 25283627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Less extensive surgery compared to extensive surgery: survival seems similar in young women with adult ovarian granulosa cell tumor.
    Lauszus FF; Petersen AC; Neumann G; Cleemann L; Rosgaard A; Jørgensen A; Vandborg M; Jakobsen A
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():61-6. PubMed ID: 24698496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecularly Defined Adult Granulosa Cell Tumor of the Ovary: The Clinical Phenotype.
    McConechy MK; Färkkilä A; Horlings HM; Talhouk A; Unkila-Kallio L; van Meurs HS; Yang W; Rozenberg N; Andersson N; Zaby K; Bryk S; Bützow R; Halfwerk JB; Hooijer GK; van de Vijver MJ; Buist MR; Kenter GG; Brucker SY; Krämer B; Staebler A; Bleeker MC; Heikinheimo M; Kommoss S; Blake Gilks C; Anttonen M; Huntsman DG
    J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27297428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk for stress urinary incontinence in women with postmenopausal hormone therapy.
    Rahkola-Soisalo P; Savolainen-Peltonen H; Gissler M; Hoti F; Vattulainen P; Ylikorkala O; Mikkola TS
    Int Urogynecol J; 2019 Feb; 30(2):251-256. PubMed ID: 29946829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.